10x Genomics, Inc.
TXG
$22.37
-$0.25-1.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.25% | 1.92% | 2.02% | -0.13% | -1.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.25% | 1.92% | 2.02% | -0.13% | -1.28% |
| Cost of Revenue | 1.24% | -5.00% | -12.02% | -10.69% | -6.40% |
| Gross Profit | 7.14% | 5.38% | 9.67% | 5.66% | 1.34% |
| SG&A Expenses | -9.36% | -2.51% | -0.64% | 0.72% | -0.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.36% | -3.84% | -3.94% | -3.30% | -1.99% |
| Operating Income | 47.60% | 24.40% | 23.90% | 12.87% | 4.19% |
| Income Before Tax | 77.54% | 58.45% | 65.99% | 40.29% | 28.57% |
| Income Tax Expenses | -26.18% | -51.36% | -19.60% | -50.83% | -22.24% |
| Earnings from Continuing Operations | 76.16% | 58.19% | 64.72% | 40.58% | 28.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.16% | 58.19% | 64.72% | 40.58% | 28.41% |
| EBIT | 47.60% | 24.40% | 23.90% | 12.87% | 4.19% |
| EBITDA | 58.80% | 29.44% | 27.35% | 13.70% | 5.32% |
| EPS Basic | 77.07% | 59.18% | 65.33% | 42.17% | 30.30% |
| Normalized Basic EPS | 56.01% | 27.05% | 28.36% | 16.21% | 5.68% |
| EPS Diluted | 77.13% | 59.30% | 65.41% | 41.98% | 30.10% |
| Normalized Diluted EPS | 56.00% | 27.03% | 28.35% | 16.21% | 5.68% |
| Average Basic Shares Outstanding | 3.56% | 3.07% | 2.72% | 2.67% | 2.81% |
| Average Diluted Shares Outstanding | 3.72% | 3.23% | 2.88% | 2.67% | 2.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |